Conference Track

Side Effects and Treatment of HIV Coinfection

Source: CCO Independent Conference Coverage of the 2004 Annual Meeting of The American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Capsule Summaries

Side Effects of Treatment

Exercise Reduces Fatigue in Patients With Chronic Hepatitis C in Pilot Study
Insulin Resistance Correlates With Steatosis in HCV/HIV-Coinfected Patients and May Contribute to Disease Progression
Ribavirin Clearance Strongly Associated With Development of Hemolytic Anemia During Treatment of HCV
Female Gender and Age Over 55 Associated With Increased Risk of Ribavirin-Induced Anemia in HCV/HIV Coinfection
Ondansetron Reduces Fatigue in Patients With Chronic Hepatitis C in Pilot Study
Simple Model Predicts Risk of Ribavirin-Associated Anemia in Transplant Patients With Hepatitis C
Factors Associated With Steatosis in HIV/HCV Coinfection Similar to HCV Monoinfection
Hepatic Steatosis Associated With More Advanced Fibrosis in HCV/HIV-coinfected Patients

Treatment of HIV Coinfection

Expert Analysis

Side Effects and Treatment of HIV Coinfection

Program Director: Patrick J. Lynch, MD

Faculty:

Nezam H. Afdhal, MD, FRCPI
Raymond T. Chung, MD
Mark S. Sulkowski, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

Evaluate recent clinical trials of peginterferon and ribavirin for the treatment of hepatitis C virus infection in HIV-infected patients
Review recent studies of approaches to reduce or avoid common side effects of hepatitis treatment
Discuss groups at higher risk for the development of side effects from treatment

Earn CME credit by reading the expert analysis and commentary on Side Effects and Treatment of HIV Coinfection.

Topics covered include:

Acute HCV in HIV-Coinfected Patients
HCV Treatment Responses in HCV/HIV Coinfection
HCV Treatment and Liver Disease Progression in HCV/HIV Coinfection
End-stage Liver Disease in HCV/HIV Coinfection
Liver Transplantation in HCV/HIV Coinfection
Hepatic Steatosis in HCV/HIV Coinfection
HBV/HIV Coinfection
Anemia as a Side Effect of HCV Therapy
Fatigue as a Side Effect of HCV Therapy
Conclusions

CME CREDIT INFORMATION

Release Date: 12/21/04

Expiration Date: 12/20/05

Physicians: maximum of 2.0 AMA PRA Category 1 Credits™

Registered Nurses: 3.9 Nursing CE credits

Pharmacists: 3.25 contact hours (0.33 CEUs)

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.